top of page


Did you know families are now choosing to preserve stem cells from their children's baby teeth, wisdom teeth and teeth removed for orthodontia?

Request our Store-A-Tooth Family Information Packet to learn more.

Nov 01, 2017

Belfast Telegraph

"Grace McCullough, a medical student at Queen's University, was moved to act after seeing first-hand the devastating effect blood cancer can have on patients during her placements at hospitals. The 22-year-old from Banbridge in Co Down, donated her cells at King's College London after being recruited by Belfast Marrow, a branch of the Anthony Nolan student volunteer network."

Oct 30, 2017

Qatar Tribune

"Allogeneic stem cell transplantation represents a new milestone in our efforts to provide the very best cancer care and treatment in Qatar. The procedure's success underlines our ongoing journey to combat cancers of the blood with the most advanced treatment modalities. Significant advances have been made throughout Qatar. We now take on the challenge of making further advances in developing our knowledge and expertise in cancer prevention and treatment to decrease the incidence of cancer in Qatar and increase survival rates, ultimately aiming to free our population from this often-devastating disease.'' 

Oct 29, 2017

The Jerusalem Post

"Patients suffering from bone-marrow failure could have better quality of life and longer survival rates following approval by the Health Ministry to extend a clinical trial of a new placenta-based cell therapy in Israeli hospitals.'' 

Oct 26, 2017

"It was so great to catch up with Chief Meteorologist Chris Bradley, who will be part of the Leukemia & Lymphoma Society's “Light the Night” walk. The event is critical to funding life-saving treatments. We also talked about his recovery after a stem cell transplant in September. Chris told us that after three stays at The James Cancer Hospital, it is good to be home."

Oct 25, 2017

News Medical

"Researchers at Fred Hutchinson Cancer Research Center and the University of Washington have developed a novel way to genetically engineer T cells that may be effective for treating and preventing leukemia relapse."

1 / 2

Please reload

bottom of page